NCT03094052 2025-06-26
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
University of California, San Francisco
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Breast Neoplasms × atropine sulfate-diphenoxylate hydrochloride drug combination × Clear all